在由聚烯二衍生过器中对卡斯波金的隔离:增加剂量不会减轻隔离的作用
Frédéric J Baud1, Vincent Jullien2, Marie Desnos-Ollivier3
1Département d'Anesthésie-Réanimation Adulte-SAMU de Paris, Hôpital Necker; Assistance Publique-Hôpitaux de Paris, University Paris Cité, Paris, France.
International journal of antimicrobial agents
|October 15, 2023
概括
在连续脏替代疗法期间,增加卡斯波金的剂量并不能阻止其在多烯二烯过器中被封存. 这突显了使用卡斯波金与这些过器的风险,建议使用替代抗真菌剂或疗法.
科学领域:
- 药理学 药理学是指药理学的学科.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 临界护理医学 临界护理医学
背景情况:
- 持续置换疗法 (CRRT) 对重症患者至关重要.
- 埃奇诺坎丁和卡斯波丁一样,是治疗白血病的第一线治疗方法.
- 预先的数据显示,埃奇诺坎丁在多烯二过器中被封存.
研究的目的:
- 调查增加卡斯波金剂量是否可以克服聚烯二烯过器中的封存.
- 为了评估CRRT过器对卡斯波金排放的影响.
主要方法:
- 在体外使用STX过器 (多烯) 的研究.
- 使用液体染色学-质谱学测量的卡斯波金度.
- 使用NeckEpur技术在晶体介质中评估药物处置.
主要成果:
- 在低剂量和高剂量下,卡斯波金在6小时内被广泛消除.
- 隔离在低剂量下排泄的96%和高剂量下排泄的88.5%.
- 增加卡斯波金剂量并没有显著减少过器封存.
结论:
- 在STX过器中,高剂量并不能减轻卡斯波金的分离.
- 同时使用caspofungin和多烯酸过器需要小心.
- 可以考虑替代CRRT模式或抗真菌剂 (例如,可纳).
相关概念视频
Drug Elimination by Renal Route: Tubular Secretion
Once the process of glomerular filtration is completed, blood carrying unfiltered drug molecules traverses through efferent arterioles and makes its way into the peritubular capillaries in the proximal tubule. A variety of carriers play a pivotal role in actively secreting drugs from these peritubular capillaries into the tubular fluid. The organic anion transporter transfers acidic drugs, against an electrochemical gradient, from the peritubular capillaries into the renal tubule cells and...
Filtration
Filtration is a physical separation process that involves passing a suspension through a porous medium to separate solids from fluids. During filtration, solids collect on the porous medium while liquids, also collectively known as the filtrate, pass through. The filtration medium is selected based on the filtration purpose, quantity, and nature of the precipitate. The general criteria for a suitable filtering medium are that it is inert, mechanically strong, nonabsorbent toward dissolved...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Generic intravenous (IV) drugs are considered bioequivalent to their branded counterparts due to their 100% bioavailability upon administration. However, variations in stability among different drug products can significantly influence their therapeutic performance, even if they are pharmaceutically equivalent.Cefuroxime, a prophylactic antimicrobial, is often used as a single-dose IV injection for patients undergoing coronary artery bypass grafting surgery. A 3 g dose typically provides...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...


